#NephMadness 2025: Logo Reveal
Kidney Week is our favorite time to share the #NephMadness 2025 logo. Many thanks to Graham Gipson @grahamgipsonmd for designing this, as he has done for the last three [...]
#NephMadness 2025: Logo Reveal
2024 Inductees to the AJKD Reviewer Hall of Fame
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial [...]
2024 Editors’ Choice Award
In 2017, we established an annual celebration of articles that our editorial team designated as “Editors’ Choice” selections. The editors are delighted to recognize the [...]
From Farm to (OR) Table: Looking Towards First-in-Human Clinical Trials for Kidney Xenotransplantation
Ian S. Jaffe is a member of the Xenotransplant Research Group at NYU Langone Health and an MD/MS trainee at the NYU Grossmans School of Medicine. His research is focused on [...]
Do Gestational Corticosteroids Associate with Childhood CKD?
Dr. Sehrish Ali (@sehrish_alii) is an Assistant Professor at Baylor College of Medicine in Houston, TX, where she completed her fellowship under the Transition of Care [...]
Highlights from the October 2024 Issue
SPECIAL ANNOUNCEMENT: In celebration of Kidney Week, the October issue of AJKD will be freely available until November 30, 2024 Editor’s Note: We asked authors of [...]
We Know the Ceiling, But Where is the Floor? An Interview on Low-Dose CKRT
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend delivering a continuous kidney replacement therapy (CKRT) dose of 20-25mL/kg/h. However, it is not [...]
Abdominal Surgery History and Peritoneal Dialysis Catheter Failure: Can We Really Know Who’s at Risk?
Dr. Michael Granda is an Acting Assistant Professor in the Division of Nephrology at the University of Washington. He completed his internal medicine residency at the [...]
Translation of Clinical Trial Outcomes Into Real Clinical Practice: An Interview
Data supporting the efficacy of preventive pharmacological therapy (PPT) to reduce urolithiasis recurrence are based on clinical trials with composite outcomes that [...]
Highlights from the September 2024 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]